Advertisement

International Journal of Hematology

, Volume 83, Issue 5, pp 404–407 | Cite as

Stable Response after Administration of Stem Cell Factor Combined with Granulocyte Colony-Stimulating Factor in Aplastic Anemia

  • Kensuke Usuki
  • Seiko Iki
  • Shunya Arai
  • Kimiko Iijima
  • Fumimaro Takaku
  • Akio Urabe
Case Report

Abstract

We report successful treatment with 25 (xg/kg of recombinant methionyl human stem cell factor (SCF) combined with 400 μxg/m2 of recombinant human granulocyte colony-stimulating factor (G-CSF) in 2 patients with aplastic anemia refractory to immunosuppressive therapy. In one patient, hemoglobin levels increased from 6.4 g/dL to 11.3 g/dL after 36 weeks of SCF/ G-CSF treatment. Thereafter, the platelet count (24.0 X 109/L) began to improve without the therapy, and as of week 272, the platelet count was 125.0 X 109/L with a leukocyte count of 8.4 X 109/L and a hemoglobin level of 12.9 g/dL. In the other patient, more than 3 years of SCF/G-CSF treatment ameliorated hemoglobin levels and platelet counts from 5.8 g/dL to 15.9 g/dL and 8.0 X 109/L to 50.0 X 109/L, respectively. After cessation of SCF/G-CSF treatment, the positive response was sustained, and the platelet count improved further to 71.0 X 109/L as of week 242. These observations suggest the clinical benefit of SCF/G-CSF administration to patients with refractory aplastic anemia.

Key words

Stem cell factor Granulocyte colony-stimulating factor Aplastic anemia Cytokine Therapy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Marsh JC, Ball SE, Darbyshire P, et al. Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol. 2003;123:782–801.CrossRefPubMedGoogle Scholar
  2. 2.
    Langley KE, Bennett LG, Wypych J, et al. Soluble stem cell factor in human serum. Blood. 1993;81:656–660.PubMedGoogle Scholar
  3. 3.
    Wodnar-Filipowicz A, Yancik S, Moser Y, et al. Levels of soluble stem cell factor in serum of patients with aplastic anemia. Blood. 1993;81:3259–3264.PubMedGoogle Scholar
  4. 4.
    Lyman SD, Jacobsen SE. c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood. 1998;91:1101–1134.PubMedGoogle Scholar
  5. 5.
    Basser RL, To BL, Begley CG, et al. Rapid hematopoietic recovery after multicycle high-dose chemotherapy: enhancement of filgrastim-induced progenitor-cell mobilization by recombinant human stem-cell factor. J Clin Oncol. 1998;16:1899–1908.CrossRefPubMedGoogle Scholar
  6. 6.
    Glaspy JA, Shpall EJ, LeMaistre CF, et al. Peripheral blood progenitor cell mobilization using stem cell factor combined with filgrastim in breast cancer patients. Blood. 1997;90:2939–2951.PubMedGoogle Scholar
  7. 7.
    Krieger SM, Nissen C, Wodnar-Filipowicz A. Stem cell factor in aplastic anemia: in vitro expression in bone marrow stroma and fibroblast cultures. Eur J Haematol. 1995;54:262–269.CrossRefPubMedGoogle Scholar
  8. 8.
    Kurzrock R, Gratwohl A, Paquette R, Wyres M, Okamoto D, Young N. Trilineage responses seen with stem cell factor (Stemgen, SCF) and filgrastim (G-CSF) treatment in aplastic anaemia (AA) patients (Pts) [abstract]. Br J Haematol. 1998;102:1. Abstract PL-0004.CrossRefGoogle Scholar
  9. 9.
    Kurzrock R, Paquette R, Gratwohl A, et al. Use of stem cell factor (Stemgen, SCF) and filgrastim (G-CSF) in aplastic anemia (AA) patients (Pts) who have failed ATG/ALG therapy [abstract]. Blood. 1997;90(suppl 1):173a.Google Scholar
  10. 10.
    Locasciulli A, Arcese W, Locatelli F, Di Bora E, Bacigalupo A, for the Italian Aplastic Anaemia Study Group. Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Lancet. 2001;357:43–44.CrossRefPubMedGoogle Scholar
  11. 11.
    Kojima S, Ohara A, Tsuchida M, et al. Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood. 2002;100:786–790.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2006

Authors and Affiliations

  • Kensuke Usuki
    • 1
  • Seiko Iki
    • 1
  • Shunya Arai
    • 1
  • Kimiko Iijima
    • 1
  • Fumimaro Takaku
    • 2
  • Akio Urabe
    • 1
  1. 1.Division of HematologyNTT Kanto Medical CenterTokyoJapan
  2. 2.Jichi Medical SchoolTochigiJapan

Personalised recommendations